A key opinion leader reviews findings presented at ID Week 2020 from a post-hoc analysis of the AMBER study comparing GI tolerability of D/C/F/TAF to TDF. Moti Ramgopal, MD, FACP, FIDSA, CPI: The ...
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today presented three-year results from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback